[ad_1]
Reuters
Alexander Gintsburg, director of the Russian Center for Microbiology Research, “Gamalia”, suggested that the vaccine “Pfizer” would face major logistical problems, since it was necessary to store it at a temperature of up to 80 degrees below zero.
He stressed that the storage and transport of this vaccine would be more difficult in Europe than the Russian vaccine “Sputnik V”, which was developed in “Gamalia” and requires to store it at 18 degrees below zero.
Ginsburg pointed out that the basis of the Russian vaccine is viruses, and it has been tested for a long time and worked well, while the duration of immunity posed by Pfizer’s RNA-based vaccine has yet to be studied. in depth.
And the American company “Pfizer” recently announced that the vaccine, which it developed in cooperation with the German company BioNTech, was more than 90% effective in the third phase of the trials which included 40,000 people.
For its part, the Russian Direct Investment Fund announced on Wednesday that the effectiveness of the Russian vaccine against the Corona virus, according to the results of post-registration studies, reached 92%, and that the Russian side had received reservations on the billion-dose “Sputnik V” vaccine so far.
Source: Interfax
[ad_2]
Source link
